Free Trial

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Shares Bought by Charles Schwab Investment Management Inc.

Sabra Health Care REIT logo with Finance background

Charles Schwab Investment Management Inc. boosted its stake in Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 2.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,190,587 shares of the real estate investment trust's stock after purchasing an additional 94,304 shares during the period. Charles Schwab Investment Management Inc. owned about 1.81% of Sabra Health Care REIT worth $59,800,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. JPMorgan Chase & Co. grew its stake in shares of Sabra Health Care REIT by 709.0% in the third quarter. JPMorgan Chase & Co. now owns 13,504,420 shares of the real estate investment trust's stock worth $188,252,000 after purchasing an additional 11,835,109 shares during the last quarter. Duff & Phelps Investment Management Co. increased its stake in shares of Sabra Health Care REIT by 58.8% during the fourth quarter. Duff & Phelps Investment Management Co. now owns 2,101,595 shares of the real estate investment trust's stock valued at $29,990,000 after buying an additional 778,355 shares during the period. American Century Companies Inc. raised its holdings in shares of Sabra Health Care REIT by 41.8% during the third quarter. American Century Companies Inc. now owns 2,109,005 shares of the real estate investment trust's stock valued at $29,400,000 after acquiring an additional 622,133 shares in the last quarter. abrdn plc lifted its stake in Sabra Health Care REIT by 108.0% in the fourth quarter. abrdn plc now owns 974,350 shares of the real estate investment trust's stock worth $13,904,000 after acquiring an additional 506,011 shares during the period. Finally, Principal Financial Group Inc. boosted its holdings in Sabra Health Care REIT by 1.5% in the third quarter. Principal Financial Group Inc. now owns 21,003,193 shares of the real estate investment trust's stock valued at $292,783,000 after acquiring an additional 313,517 shares in the last quarter. Institutional investors own 99.40% of the company's stock.


Sabra Health Care REIT Stock Up 1.0 %

Shares of NASDAQ:SBRA traded up $0.15 on Friday, hitting $14.33. 1,454,021 shares of the company traded hands, compared to its average volume of 2,027,120. The stock has a 50 day simple moving average of $14.21 and a 200-day simple moving average of $14.06. The company has a quick ratio of 4.33, a current ratio of 4.33 and a debt-to-equity ratio of 0.89. The company has a market cap of $3.32 billion, a PE ratio of 71.10, a PEG ratio of 5.21 and a beta of 1.17. Sabra Health Care REIT, Inc. has a 52 week low of $10.30 and a 52 week high of $14.92.

Sabra Health Care REIT Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 31st. Shareholders of record on Monday, May 20th will be issued a $0.30 dividend. The ex-dividend date is Friday, May 17th. This represents a $1.20 annualized dividend and a yield of 8.37%. Sabra Health Care REIT's dividend payout ratio (DPR) is presently 600.00%.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the stock. Deutsche Bank Aktiengesellschaft initiated coverage on shares of Sabra Health Care REIT in a research report on Tuesday, January 30th. They issued a "buy" rating and a $21.00 target price for the company. Scotiabank lifted their price objective on Sabra Health Care REIT from $14.00 to $15.00 and gave the company a "sector perform" rating in a research report on Wednesday. Finally, Wedbush reiterated an "outperform" rating and set a $17.00 target price on shares of Sabra Health Care REIT in a report on Thursday, February 29th. Six research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $15.71.

Check Out Our Latest Report on SBRA

Sabra Health Care REIT Profile

(Free Report)

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.

Recommended Stories

Institutional Ownership by Quarter for Sabra Health Care REIT (NASDAQ:SBRA)

Should you invest $1,000 in Sabra Health Care REIT right now?

Before you consider Sabra Health Care REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.

While Sabra Health Care REIT currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Will FOMC Push Stocks Higher? Here’s What to Expect
Unlock Growth: Understanding Dividend Yield
Palantir Stock Excluded from S&P 500: Still a Buy?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines